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Abstract 
The development of new strategies for detecting miRNAs has become a crucial step in the diagnostic 
field. miRNA profiles depend greatly on the sample and the analytical platform employed, leading 
sometimes to contradictory results. In this work we study the use of modified parallel tail-clamps to detect 
a miRNA sequence involved in tumor suppression by triplex formation. Thermal denaturing curves and 
CD measurements have been performed to confirm that parallel clamps carrying 8-aminoguanine form the 
most stable triplex structures with their target miRNA. The modified tail-clamps have been tested as 
bioreceptors in a SPR biosensor for the detection of miRNA-145. The detection limit was improved 2.4 
times demonstrating that a stable triplex structure is formed between target miRNA and 8-aminoguanine 
tail-clamp bioreceptor. This new approach is an essential step toward the label-free and reliable detection 
of miRNA signatures for diagnostic purposes.  
 
Keywords Triplex, target miRNA-145, SPR biosensor, parallel tail-clamp, 8-amino-2’-
deoxyguanosine. 
 
Introduction 
MicroRNAs (miRNAs) are short RNA molecules (on average only 22 nucleotides long) that play 
important role in many basic biological processes including development, cell proliferation, 
differentiation and apoptosis [1]. Several thousands of miRNA have been identified as regulatory 
molecules of gene expression at the post-transcriptional level and also have been used as a new tool in 
medical diagnosis [2]. The mechanisms of action of miRNA are not yet fully characterized but expression 
levels of specific miRNA in tissues have already been correlated with several diseases. In fact detection of 
differential expression of miRNA can provide valuable diagnostic and prognostic data [3, 4]. 
Measuring miRNAs instead of traditional protein biomarkers is still a very challenging task. Given the 
miRNAs size and levels in cells, the detection methods need to be extremely sensible and selective in 
small amounts of complex RNA sample. 
The Northern blot and real-time quantitative polymerase reaction (qPCR) are the most used methods for 
miRNA detection [5, 6]. However, the first one requires large amounts of sample whereas the second one 
is not always accurate in miRNA measurements. In addition to these methods, microarray technology has 
been applied to parallelized detection of multiple miRNAs [7]. In this case it is particularly difficult to 
design very specific probes for a number of miRNAs and sometimes also to distinguish real signals from 
non specific hybridization. Differences in microRNA detection levels are technology and sequence 
dependent [8]. Several reviews have been published dealing with microRNA detection and quantification 
by conventional amplification-based molecular strategies or by using amplification-free biosensor-based 
methods [9-11]. These last techniques have been used to complement the first ones although recent results 
have shown that biosensors can deliver high sensitivity (aM-nM levels), minimal sample preparation and 
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rapid measurements that provide excellent characteristics for clinical diagnosis as well as fundamental 
research. The main molecular recognition event in miRNA biosensors is the hybridization of target 
miRNA with a typically DNA probe of complementary sequence. The quantitative recognition is 
transduced in a measurable electrochemical [12], electromechanical [13] or optical signal [14]. Surface 
plasmon resonance (SPR) offered rapid, sensitive and on-site analysis of miRNA [14]. This method has 
been applied to quantify mature mir-122 in a complex sample at subfemtomole level [14]. The detection 
protocol is based on the recognition of DNA-RNA hybrid duplex by a specific antibody. In addition, a 
method for detection of miRNA with excellent sensitivity has been described by SPR imaging and DNA-
coated nanoparticles [15]. All the described methods rely on duplex formats between the miRNA and the 
complementary probe. Nevertheless, alternative formats can also be used to detect miRNA. Triple-helix 
formation based on Hoogsteen base pairing to the Watson-Crick duplex is an interesting alternative. 
Triplex can only be formed at specific polypurine-polypyrimidine sequences but these triple-helix target 
sites are widespread within the human genome, especially at promoter regions [16-18].  
Previously, our group reported the triplex-stabilizing properties of 8-aminopurines [19, 20] and the use of 
parallel and antiparallel tail clamps to increase the efficiency of triplex formation with structured DNA 
and RNA targets [21]. All this knowledge was applied to develop a new affinity capture technique based 
on the stability of triplex by using tail-clamps carrying 8-aminopurines as bioreceptor [22)]. Recently, we 
applied this triplex affinity capture strategy for the detection of Listeria mRNA using a SPR biosensor 
[23]. 
Here, we have described the triple-helix formation of parallel clamps containing 8-amino-2’-
deoxyguanosine and miRNA-145. This miRNA has been shown to act as a tumor suppressor, as in most 
of the human cancer cell lines, a clear reduction of the expression of this miRNA was observed. In 
particular, low-expression in human colon or gastric cancer cells has been reported [24], with a clear 
relationship between the expression of miRNA-145 and the clinicopathological findings in human 
colorectal tumors. On the basis of such findings, we have developed a new strategy to capture and 
measure miRNA-145 by SPR based in the formation of stable triplex structures. 
 
Materials and Methods 
 
Synthesis of Oligonucleotides 
 
Oligonucleotides used in this study are listed in Table 1S and 2S. The parallel-stranded clamps were 
designed to carry the polypurine sequence with additional bases complementary to miRNA-145, 
connected head-to-head and through their 3’-ends with the Hoogsteen C, T sequence. A tetrathymidine 
sequence was used in the loop to connect the two strands. First, the purine part was assembled by using 
standard phosphoramidites for the natural bases and 8-aminoguanine phosphoramidite from commercial 
sources, then a tetrathymidine loop sequence was added. Finally, the heptapyrimidine sequence was 
prepared by using reversed C and T phosphoramidites. 
 4 
 Oligonucleotides for biosensing were prepared as described with additional 15 thymidines and 5’ 
thiol modifier –C6 S-S CE phosphoramidite (Link Technologies) in the 5’-end.  
 Sequences were prepared on an Applied Biosystems 3400 synthesizer using polystyrene solid 
supports (LV200) according to the protocols of the manufacturer. The dimethoxytrityl group of the last 
phosphoramidite was not removed to facilitate reversed-phase purification (DMT-on protocol). Standard 
protecting groups were used for DNA sequences (ABz, Gibu, CBz,, T). The RNA oligonucleotide, miRNA-
145, was synthesized using 2'-O-TBDMS protected phosphoramidites (ABz, Gdmf, CAc and U). 
Oligonucleotides containing 8-AminoG were prepared using commercial available phosphoramidite 
(Berry & Associates). After assembling of the sequences, oligonucleotide supports were treated with 
aqueous ammonia (32%) for 16h at 55ºC for DNA sequences and 1h at 55ºC for RNA sequence. Addition 
of β-mercaptoethanol was used in the deprotecting solutions in sequences containing 8-AG. The ammonia 
solutions were concentrated to dryness and for DNA sequences the product was desalted on NAP-10 
(Sephadex G-25) columns eluted with water. For miRNA-145, after ammonia treatment, the residue was 
dissolved in a total volume of 85 µL of 1M TBAF in THF and rocked at room temperature for 12 h. 
Then, 85 µL of 1M triethylammonium acetate (TEAA) and 330 µL of water were added to the solution. 
The oligonucleotide was desalted in a NAP-5 column using water as the eluent and evaporated to dryness. 
All the oligonucleotides were purified by HPLC (DMT-ON). Oligonucleotides for biosensing were 
deprotected with aqueous ammonia (32%) for 16 h at 55ºC with 0.1 M DTT. 
 Column: Nucleosil 120-10 C18 (250x4 mm); 20 min linear gradient from 15%  to 80% B and 5 
min 80% B, flow rate 3 mL/min; solution A was 5% ACN in 0.1 M aqueous TEAA and B 70% ACN in 
0.1 M aqueous TEAA. The pure fractions were combined and evaporated to dryness. The residue that was 
obtained was treated with 1 mL of 80% AcOH solution and incubated at room temperature for 30 min. 
The aqueous phase is extracted with diethylether and, finally, the deprotected oligonucleotide was 
desalted in a NAP-10 column. All oligonucleotides were quantified by absorption at 260 nm and 
confirmed by MALDI mass spectrometry (see supplementary Table S1 and S2 online). 
 
Thermal UV Denaturation and CD studies 
 The absorbance versus temperature curves of duplexes and triplexes were measured at 1.7 µM 
strand concentration in 0.1 M sodium phosphate/citric acid buffer at pH 5 and pH 6 or in 0.1 M sodium 
phosphate buffer at pH 7, all the buffers are implemented with 1M NaCl. Thermal UV experiments were 
performed in Teflon-stopped 1 cm path length quartz cells on a JACSO V-650 spectrophotometer 
equipped with thermoprogrammer. The samples were heated to 90ºC, allowed to slowly cool down to 
20ºC, and then warmed during the denaturation experiments at a rate of 0.5 ºC/min to 85 ºC, monitoring 
absorbance at 260 nm and 300 nm. The data were analyzed by the denaturation curve processing program, 
MeltWin v. 3.0. Melting temperatures (Tm) were determined by computerfit of the first derivative of 
absorbance with respect to 1/T. 
 CD measurements were recorded at the same strand concentration as denaturing curves. Spectra 
were recorded on a JASCO spectropolarimeter J-810 and registered at 15ºC over a range of 205-320 nm 
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with a scanning speed of 100 nm/min, a response time of 4 s, 0.5 nm data pitch and 1nm bandwidth. The 
samples were dissolved in the above buffers annealed and slowly cooled down to room temperature and 
left at 4ºC at least one night. 
 
Experimental Procedure for Detection Using the SPR Biosensor 
 SPR biosensor device: We employed a home-made SPR23. The SPR sensor platform is based on 
Kretschmann configuration, monitoring the binding events in real time. A p-polarized light of 670 nm 
from a laser source is divided in two identical beams focused on the crystal-backside of the sensor chip 
(glass surface coated with 2 nm of chromium and 45 nm of gold, 10x10x0.3 mm). Measurements are 
performed at a fixed angle of incidence. Variations of the refractive index (RI) due to the biointeraction 
events occurring at the sensing surface are detected as changes in the reflected light intensity by a 
multielement photodiode, permitting a label-free detection. The flow system consists of two flow cells 
(300 nL each) for two simultaneous and independent analysis. The device incorporates all optics, 
electronics and fluidics components necessary to operate autonomously. Sensograms reproduce the 
binding events by monitoring the increase (or decrease in case of unbinding events) of the intensity of the 
reflected light (ΔReflectivity (%), ΔR (%)) vs. time (seconds, s). This change of the intensity of the 
reflected light is directly related to changes in the RI of the dielectric medium caused by mass changes (as 
a biomolecular interaction) on the metal surface. 
 Gold sensor chips (SSens, Enschede –The Netherlands-) are used as the sensing element. They 
are cleaned prior to experiments by rinsing with solvents of decreasing polarity (i.e. trichloroethylene, 
acetone, ethanol and dH2O) previously heated up to their boiling point. Then, sensor chips are dried under 
nitrogen (N2) flux and dipped into piranha solution (H2SO4:H2O2 volume ratio 7:3) for a few seconds, 
rinsed again with water and dried under N2 flux.  
Bioreceptor immobilization: The different bioreceptors were tested in independent assays. Clean gold 
biosensor chips were coated ex situ by 100 mL of immobilization solutions (1µM DNA receptor with 50 
nM Mercaptohexanol (MCH) (Sigma Aldrich, Steinhem –Germany-) in PB buffered solution (50 mM 
Phosphate buffer- 0.75 mM NaCl, pH 7)) and kept in a humid chamber for 3 h. Then, they were rinsed in 
DEPC treated H2O, dried under N2 flux and placed in the sensor device. 
 Detection was done in situ at room temperature (RT) by flowing different concentrations of 
miRNA-145 over the sensor surface for their hybridization with the different immobilized bioreceptors at 
a 16 µL/min constant rate. These samples were dissolved in 5X-SSC solution (0.75 M in NaCl, 0.075 M 
in sodium citrate, pH 7). Regeneration after hybridization was achieved by injecting a 35% formamide 
solution, allowing the analysis of a high number of interactions using the same bioreceptor monolayer. 
Material sterilization: To keep RNase free conditions during measurements, sensor microfluidic was 
cleaned by flowing sequentially SDS 0.5%, HCl 0.1 M, EtOH 100%, NaOH 0.1 M and sterile H2O. The 
buffers and other solutions were prepared by using H2O milliQ incubated O/N with 2% DEPC and 
autoclaved at 121ºC during 30 min. All solid materials were autoclaved at 121ºC/20 min for plastic 
materials and 134ºC/10 min for glass ones.  
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Data analysis: The data were collected using Origin 8.0 software (OriginLab, Northampton, MA). The 
experimental detection limit was defined as the target concentration giving a ΔR (%) in the hybridization 
signal at least three times higher than that of the standard deviation of RNA control signal. Limits of 
quantification were defined as the target concentration giving ΔR (%) in the hybridization signal at least 
ten times higher than that of the standard deviation of the RNA control signal. 
 
Results 
We designed and synthesized parallel clamps (PT Clamp, 3AG PT Clamp, Fig. 1a) targeting a 7-
homopyrimidine sequence of miRNA-145 in order to assess their capacity to form triple helices. The 
homopurine portion is extended in order to hybridize the target miRNA-145 with Watson-Crick 
interactions and the inverted homopyrimidine portion of the clamps should form a triplex by Hoogsteen 
hydrogen bonding. Base-pairing scheme of the triads that forms the triplex structures is showed in Figure 
1b. 3AG PT Clamp contains three consecutive 8-aminoguanines (8-aminoGs). The 7-base polypyrimidine 
track of the miRNA-145 is shorter than 12-bases used in previous studies [23]. To overcome this problem 
and to improve the triplex formation we decided to use 8-aminoG modification instead of 8-aminoA due 
to their improved triplex formation efficacy. 8-aminoG increased triplex stability around 10 ºC / per 
substitution in contrast to 7 ºC of 8-aminoA [19]. Complementary sequences to miRNA-145 were 
prepared with or without 8-aminoG to study the effect of this derivative in RNA-DNA Watson-Crick 
duplexes. Formation of stable triplex structures was confirmed by UV denaturing curves and CD 
measurements. 
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Fig.1 Scheme showing the binding of tail-clamps and complementary sequences to miRNA-145 yielding 
triplex and duplex structures respectively (a) and scheme showing the triads that forms triplex structures 
C+ -8-aminoG - C and T-A-T (b). 
 
Thermal UV and CD Studies of Duplex and Triplex Structures with miRNA-145 
 The thermal stability of the complex formed between parallel clamps and miRNA-145 was 
analyzed at pH 5 which should be optimal for parallel-triplex formation (Table 1). A single transition was 
observed at 260 nm that corresponds to the denaturation of either triplex or duplex to single stranded (SS) 
form (Fig. 2a). The presence of triplex was confirmed by measuring the melting curves at 300 nm. At this 
wavelength an increased on the UV-absorption is observed (Fig. 2b) only if triplex is formed as the 
transition is due to the deprotonation of cytosine [21,22]. Moreover, 3AG PT clamp forms a more stable 
triplex than with PT clamp. Also it was observed that the melting temperature of the transition followed at 
300 nm is lower than the transition followed by 260 nm, indicating that the Hoogsteen polypyrimidine 
strand dissociates before the strands forming the Watson-Crick duplex. However, at higher pH values (pH 
6-7), only 3AG PT clamps are capable of forming stable triplexes, and the melting temperature is similar 
from the measurement performed at 260 nm and at 300 nm. Single transitions were also observed at pH 7 
but in this case the transition became broad.  
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Fig. 2 UV Melting Curves. (a) Normalized UV melting curves of complementary mi-RNA145 sequences 
and PT Clamps with miRNA-145 at 260 nm. (b) Normalized UV melting curves of PT Clamps alone and 
with miRNA-145 at 300 nm. 
 
 Additionally, we also measured the transition between control clamps in the presence or in the 
absence of 8-aminoG in which the pyrimidine strand was not appropriate to form triplex structure. In this 
case, no triplex transition was observed and the results were similar to duplex transition (Table 1). 
 
Table 1. Melting Temperatures (Tm) of Duplexes and Triplexes. Conditions: 0.1 M sodium phosphate 
buffer and citric acid at the appropriate pH with 1M NaCl. The first value corresponds to the value of the 
Tm obtained measuring the absorption at 260 nm and the second one correspond to the value obtained if 
the melting curve is measured at 300 nm. Uncertainties in Tm values are estimated at ±1 ºC 
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Sequences Expected 
transition 
Tm (ºC) pH 5  Tm (ºC) pH 6 Tm (ºC) pH 7 
PT Clamp + miRNA-
145 
TriplexSS 63.7 /56.8 65.0 / none 66.0 / none 
3AG Clamp + 
miRNA-145 
TriplexSS 75.9 / 68.7 71.4 / 71.0 57.5 / 58 
PT Clamp 
Parallel 
duplexSS 
50.5 49.8 48.2 
3AG Clamp 
Parallel 
duplexSS 
63.5 58.6  39.4 
Compl miRNA-145 + 
miRNA-145 
Antiparallel 
duplexSS 
64.1 67.2 67.7 
3AGCompl miRNA-
145 + miRNA-145 
Antiparallel 
duplexSS 
68.9 57.5 57.8 
Control Clamp+ 
miRNA 145 
Antiparallel 
duplexSS 
68.5  57.0 56.9 
3AG Control 
Clamp+miRNA-145 
Antiparallel 
duplexSS 
64.6 64.9 65.9 
 
 Thermal stability of parallel clamps alone (without miRNA target) was also studied at different 
pHs (Table 1). Thermal UV melting techniques of unmodified PT Clamp showed almost similar Tm in all 
pHs in contrast to the 3AG Clamp, that showed a strong dependence with the pH. The stability of 3AG 
Clamp is decreased with the pH. At pH 5, the difference between 3AG and the unmodified clamp is 13 ºC 
whereas at pH 7 the unmodified clamp has a Tm higher than the 3AG Clamp does. Hoosgsteen hydrogen 
bonds are affected by the protonation of the cytosines, so that at a lower pH they are more stable. This is 
the case of 3AG PT clamp. By contrast, the PT clamp is almost not affected by the pH. In this case, the 
main and most stable species may be a bimolecular antiparallel Watson-Crick duplex formed by the 
purine track of one clamp and the pyrimidine track of a second molecule in opposite direction. The 
parallel clamp may be a minor component. This is also in agreement with the similar melting temperature 
of the 3AG clamp at 300 nm and at 260 nm at pH 5 and 6. Absorbance changes at a longer wavelength 
have been described to indicate transitions in which the protonation of cytosines are required [25]. 
 Melting temperatures of heteroduplex formed by mixing miRNA-145 and the DNA 
complementary strand were similar at pH 6 and 7 but the presence of 8-aminoG decreased the stability of 
these duplex. In contrast to this, at pH 5 the duplex with 8-aminoG is more stable than the unmodified 
duplex. Secondary structures of mi-RNA145, Compl miRNA-145 and 3AG compl miRNA-145 were 
discarded as no melting was observed at any studied pHs. 
 The CD spectra of the triplex formed between the clamps and the target miRNA-145 and as well 
as the clamps alone were analyzed at pH 6 and are shown in Figure 3. The appearance of a more intense 
negative band near 210-220 nm in the CD spectra indicates the formation of a triplex [26-28].  
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Fig. 3 CD spectra of PT Clamp alone and with miRNA-145 (a) and 3AG PT Clamp alone and with 
miRNA-145 (b) in 100 mM phosphate buffer and 1 M NaCl pH 6. 
 
Detection of miRNA-145 Using Parallel Clamps 
 
 SPR biosensor offers rapid, sensitive and label-free analysis of nucleic acids sequences. This 
technique uses complementary DNA bioreceptors immobilized in a gold sensor chip to target specific 
nucleic acid sequences. The binding event is detected by alterations of the optical properties of the gold 
surface. Minute variations in the refractive index caused by the nucleic acid hybridization change the 
intensity of the reflected light, permitting the real time monitoring of the capture. In this work, we 
analyzed the use of tail clamps bioreceptors immobilized on the gold sensor chip for the detection of 
miRNA-145 (Fig. 4a). Previously reported results with SPR biosensor using tail clamps carrying 8-
aminoadenine as bioreceptors showed that, this approach was able to successfully detect structured and 
long RNAs such as mRNA of Listeria [23]. The pyrimidine track of the tail clamps contained 12 
nucleotides providing quite stable triplex structures. However, for the detection of miRNA we face an 
important challenge since miRNAs are small RNA molecules and the Hoogsteen polypyrimidine tracks 
are shorter (7 nucleotides for the miRNA-145) which might affect the stability of the clamp and the 
hybridization efficiency to form triplexes. For this reason, we used 8-aminoG instead of 8-aminoA to 
improve the triplex stability. 
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Fig. 4 Scheme of the gold sensor chip functionalized with the 3AG PT Clamp bioreceptor (a). Schemes of 
the different bioreceptors employed for the SPR biosensor study. LODs obtained for each bioreceptor are 
indicated (b). SPR calibration curves of the detection of miR-145 with different bioreceptors. The 
sensitivity for each bioreceptor was considered as three times the baseline noise standard deviation 
(discontinuous red line) All data show mean ± SD from the SPR-equilibrium signal of triplicate 
measurements (c). Real-time sensograms of 30 nM miRNA-145 using the different bioreceptor variants 
Dashed arrow indicates the equilibrium signal of the SPR sensograms (d). 
 
 To assess the advantage of this new triplex structure as a bioreceptor in a SPR biosensor for the 
detection of miRNAs, we designed two PT clamp bioreceptors, one modified 8-aminoG (3AG Clamp) 
and other with no 8-aminoG modification (PT Clamp). For comparison purposes, we also assayed duplex 
formation capture in which complementary sequences to miRNA-145 were prepared with and without 8-
aminoG (3AG Compl. miR-145 and Compl. miR-145, respectively). In addition, we analyzed tail clamp 
controls which include incorrect polypyrimidine sequence in which the triplex was unable to form 
properly (3AG Control Clamp and Control Clamp). Schematic representations of all the employed 
bioreceptors are depicted in Figure 4b. Bioreceptor sequences are shown in Table 2S. 
 For the gold sensor chip functionalization, all bioreceptors were modified with a thiol-group at 
the 5’-end of the Hoogsteen pyrimidine track for their attachment to the gold surface by chemisorption 
through thiol-gold chemistry. We include a block of 15 thymidine nucleotides (Poly-T15) as a vertical 
spacer in order to improve the accessibility of the miR-145 target to the bioreceptor monolayer as 
previously reported23. In addition, we used 6-mercapto-1-hexanol as a lateral spacer to minimize steric 
hindrance29. Gold sensor chips were coated ex situ with the immobilization solutions and were kept under 
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an humid chamber for 3 h. During the incubation time, thiolated bioreceptors arrange themselves 
spontaneously into a so-called self-assembled monolayer (SAM).  
 Results of SPR detection of miRNA-145 with all the bioreceptors are displayed in Figure 4 b-d. 
We evaluated the efficiency of all the bioreceptors by monitoring their response to standard solutions at 
different miR-145 concentrations ranged from 2 nM to 30 nM. Triplicate measurements of each miR-145 
concentration were obtained and calibration curves for each bioreceptor have been represented (Figure 4c 
and Figure S1 Electronic Supplementary Material). The limit of detection (LOD) of each bioreceptor has 
been calculated and listed in Figure 4b. The specificity of the bioreceptor was confirmed by measuring the 
sensogram with a different miRNA (miRNA-194) with similar GC content (Figure S2, Electronic 
Supplementary Material).  
Real-time sensograms of miR-145 at 30 nM with each bioreceptor (Figure 4d) showed an increase in the 
sensor response of miRNA-145 for the PT clamp bioreceptors compared with the duplex ones. In 
addition, their sensitivities were improved exhibiting more than 1.5 times lower LODs. On the other hand, 
8-aminoG modifications seem to largely stabilize the hybridization, obtaining higher signals with 
bioreceptors containing them as compared with the non-modified ones. The duplex detection approach is 
favored when the complementary bioreceptor is modified with 8-aminoG in accordance with the UV-
denaturing data. Furthermore, the introduction of these modifications in the PT Clamp bioreceptor 
promoted the stabilization of the triplex as they showed the maximum biosensor response, leading to an 
enhancement of the sensitivity.  A LOD of 1 nM was determined for 3AG Clamp bioreceptor, rendering 
in a LOD 2.43 times lower as compared to the standard duplex bioreceptor. Surfaces biofunctionalized 
with unmodified PT Clamp receptors generated a LOD of 1.65 nM, very similar to the one obtained for 
the duplex-forming 3AG Compl. bioreceptor (1.60 nM). This result suggests that under our experimental 
conditions, a triplex structure is only formed with 8-aminoG-modified parallel tail-clamps. 
 
Discussion 
 
Searching new strategies for detecting miRNA has become an intensive research field. miRNA 
profiles depend greatly on the sample and on the analytical platform and protocols used and  results are 
not always consistent. Developing a different sensitive and label-free method will have a potential 
application in profiling miRNA expression as signatures for clinical diagnostics. 
 U.V denaturing and CD measurements have been used to study the formation of stable triplex 
structures with tail-clamps and miRNA-145. The introduction of 8-amino-2’-deoxyguanosine derivatives 
into parallel tail clamps are the key in the formation of stable triplex structures when the binding 
pyrimidine sequence of the target miRNA-145 is relatively short. These results were applied to provide a 
new and sensitive approach for label-free detection of miRNA-145 using a SPR biosensor. A stable 
triplex structure was formed at a neutral pH by using parallel tail-clamps bioreceptors modified with 8-
aminoguanine derivatives with a short polypyrimidine track.  
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 This modified tail-clamp was more efficient for target detection than the conventional duplex 
formats. The introduction of 8-aminoG in both triplex- and duplex-capture probes was found to stabilize 
the hybridization, improving the LODs in more than 1.5 times. The sensitivity of this approach provided 
levels that are in the range of the reported optical miRNA biosensors [11].  
 This novel approach is not universal but offers great potential for miRNA detection or in any 
other RNA structure; in this case the requirement was to have only seven pyrimidines in the sequence in 
order to design an appropriate tail-clamp receptor. Sequence analysis over one hundred of reported 
human miRNA was conducted. More than one third of miRNA sequences contained tracks of up to seven 
pyrimidines in their sequence. In addition, modified PT clamps may be redesigned to cope with small 
interruptions in the polypyrimidine target sequence [19] and accordingly, more miRNA sequences could 
be detected using this approach. 
 The specificity of this method comes from the extended purine track of the PT clamps that 
recognize the miRNA sequence. The purine track is extended with several nucleotides being perfectly 
complementary to miRNA though Watson and Crick hydrogen bonds. The addition of these nucleotides 
stabilizes the clamp and increases the specificity of the recognition for their target. 
 Stable triplex have been described between double helix DNA and miRNA. There is evidence 
that transcriptional gene silencing over promoter regions mediated by triplex structures occurs in the cell 
[30, 31] and the complex miRNA-DNA.DNA triplex has been found that is stabilized by proteins [32]. In 
particular, Triplex-forming complexes between human miRNAs (hsa-miR) that are complementary to 
human immunodeficiency virus (HIV-1) have been explored as antiviral therapeutic agents [33]. All these 
studies show the interest on triplex formation in the field of miRNA and other RNA regulatory elements. 
This work will expand this interest towards the detection of therapeutic miRNA that can form stable 
triplexes. These specific polypurine-polypyrimidine sequences are abundant at promoter regions [16-18]  
. 
 More work is still needed to extend this study to the detection of miRNA containing pyrimidine 
tracks with small number of polypyrimidine tracks or to miRNA having interruptions in the polypurine-
polypyrimidine track. The achieved results are an exceptional advance toward the detection of miRNA for 
diagnostic and biomedical purposes. As the detection of the differential expression of microRNA is 
important in the prognostic and prediction of several diseases, we believe that these findings are 
significant in producing a new approach to detect miRNA and in the development of a general sensing 
platform for miRNA detection in biological samples. 
 
Acknowledgments 
This work was partially supported by grants of the Spanish Ministry of Economy (MINECO) (CTQ2010-
20541 and CTQ2014-52588-R), Generalitat de Catalunya (2009/SGR/208, 2014/SGR/624) and CIBER-
BBN. CIBER-BBN is an initiative funded by the VI National R&D&i Plan 2008–2011, Iniciativa Ingenio 
2010, Consolider Program, CIBER Actions and financed by the Instituto de Salud Carlos III with 
assistance from the European Regional Development Fund.  
 14 
 
Conflict of Interest: The authors declare that they have no conflict of interest 
 
References 
 
1. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nature Reviews 
Genetics 5: 522-531. 
 
2. Debernardi S, Skoulakis S, Molloy G, Chaplin T, Dixon-McIver A, Young BD (2007) MicroRNA 
miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its 
target genes in global genome-wide analysis, Leukemia 21: 912–916. 
 
3. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu C, Franssila K, Suster 
S, Kloos RT, Croce CM, de la Chapelle A (2005) The role of microRNA genes in papillary thyroid 
carcinoma. Proceedings of the National Academy of Sciences USA 102:19075-19080. 
 
4. Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD, Golub TR, Pieske B, Pu WT (2007). Altered 
microRNA expression in human heart disease, Physiological Genomics 31: 367-373 
 
5. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. (2002) Identification of 
tissue-specific microRNAs from mouse. Current Biology, 12: 735–739 
 
6. Benes V, Castoldi M (2010) Expression profiling of microRNA using real-time quantitative PCR, how 
to use it and what is available. Methods, 50: 244–249 
 
7. Thomson JM, Parker J, Perou CM, Hammond SM (2004) A custom microarray platform for analysis of 
microRNA gene expression, Nature Methods, 1: 47–53 
 
8. Leshkowitz D, Horn-Saban S, Parmet Y, Feldmesser E (2013) Differences in microRNA detection 
levels are nanotechnology and sequence dependent. RNA, 19: 527-538 
 
9. Degliangeli F, Pompa PP, Fiammengo R (2014) Nanotechnology-based strategies for the detection and 
quantification of microRNA, Chemistry an European Journal 20: 9476-9492 
 
 15 
10. Dong H, Lei J, Ding L, Wen Y, Ju H, Zhang X (2013) MicroRNA: function, detection, and 
bioanalysis. Chemical Reviews 113: 6207–6233 
 
11. Johnson BN, Mutharasan R (2014) Biosensor-based microRNA detection: techniques, design, 
performance, and challenges. Analyst 139: 1576-1588 
 
12. Dong H, Jin S, Ju H, Hao K, Xu LP, Lu H, Zhang X (2012) Trace and label-free microRNA detection 
using oligonucleotide encapsulated silver nanoclusters as probes. Analytical Chemistry 84: 8670–8674 
 
13. Johnson BN, Mutharasan R (2012) Sample preparation-free, real-time detection of microRNA in 
human serum using piezoelectric cantilever biosensors at attomole level. Analytical Chemistry 84: 10426–
10436 
 
14. Šípová H, Zhang S, Dudley AM, Galas D, Wang K, Homola J, (2010) Surface plasmon resonance 
biosensor for rapid label-free detection of microribonucleic Acid at bubfemtomole level, Analytical 
Chemistry 82: 10110–10115 
 
15. Fang S, Lee HJ, Wark AW, Corn RM (2006) Attomole microarray detection of microRNAs by 
nanoparticle-amplified SPR Imaging measurements of surface polyadenylation reactions. Journal of the 
American Chemical Society 128: 14044-14046 
 
16. Morgan AR, Wells RD (1968) Specificity of the three-stranded complex formation between double-
stranded DNA and single-stranded RNA containing repeating nucleotide sequences. Journal of Molecular 
Biology 37: 63-80 
 
17. Goñi JR, de la Cruz X, Orozco M (2004) Triplex‐forming oligonucleotide target sequences in the 
human genome, Nucleic Acids Research 32: 54-360 
 
18. Goñi JR, Vaquerizas JM, Dopazo J, Orozco M (2006) Exploring the reasons for the large density of 
triplex-forming oligonucleotide target sequences in the human regulatory regions, BMC Genomics 7: 63 
 
19. Aviñó A, Frieden M, Morales JC, García de la Torre B, Güimil García R, Azorín F, Gelpí JL, Orozco 
M, González C, Eritja R (2002) Properties of triple helices formed by parallel-stranded hairpins 
containing 8-aminopurines. Nucleic Acids Research 30: 2609-2619 
 
 16 
20. Aviñó A, Morales JC, Frieden M, de la Torre BG, Güimil Garcı́a R, Cubero E, Luque FJ, Orozco M, 
Azorı́n F, Eritja R (2001) Parallel-stranded hairpins containing 8-aminopurines. Novel efficient probes for 
triple-helix formation, Bioorganic & Medicinal Chemistry Letters 11:1761–1763 
 
21. Nadal A, Eritja R, Esteve T, Pla M (2005) “Parallel” and “antiparallel tail-clamps” increase the 
efficiency of triplex formation with structured DNA and RNA targets, ChemBioChem, 6: 1034-1042. 
 
22. Nadal A, Coll A, Aviñó A, Esteve T, Eritja R, Pla M (2006) Efficient sequence specific purification 
of Listeria innocua mRNA Species by triplex affinity capture with parallel tail clamps. ChemBioChem 7: 
1039-1047 
 
23. Carrascosa LG, Gómez-Montes S, Aviñó A, Nadal A, Pla M, Eritja R, Lechuga LM (2012) Sensitive 
and label-free biosensing of RNA with predicted secondary structures by a triplex affinity capture method, 
Nucleic Acids Research 40: e56. 
 
24. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N, Akao Y. (2009) Decreased expression of 
microRNAs-143 and -145 in human gastric cancers, Oncology 77: 12–21 
 
25. Mergny JL, Lacroix L (1998) Kinetics and thermodynamics of i-DNA formation: phosphodiester 
versus modified oligodeoxynucleotides. Nucleic Acids Research 26: 4797-4803 
 
26. Gowers DM, Fox KD (1999) Towards mixed sequence recognition by triple helix formation. Nucleic 
Acids Research 27: 1569–1577 
 
27. Sugimoto N, Wu P, Hara H, Kawamoto Y (2001) pH and cation effects on the properties of parallel 
pyrimidine motif DNA triplexes Biochemistry, 40: 9396–9405. 
 
28. Liu K, Miles HT, Frazier J, Sasisekharan V (1993) A novel DNA duplex. A parallel-stranded DNA 
helix with Hoogsteen base pairing. Biochemistry, 32: 11802–11809 
 
29. Carascosa L G, Calle A, Lechuga L M (2009) Label-free detection of DNA mutations by SPR: 
application to the early detection of inherited breast cancer. Anal. Bioanal. Chem.  393: 1173-1182  
 
 17 
30. McGuffie EM, Catapano, CV (2002) Design of a novel triple helix-forming 
oligodeoxyribonucleotides directed to the major promoter of the c-myc gene. Nucleic Acids Res. 30: 
2701-2709 
 
31. Winters TA (2000) Gene targeted agents: new opportunities for rational drug development. Curr. 
Opin. Mol.Ther. 2: 670-681  
 
32. Toscano-Garibaya JD,   Aquino-Jarquin G (2014) Transcriptional regulation mechanism mediated by 
miRNA–DNA•DNA triplex structure stabilized by Argonaute. Biochimica et Biophysica Acta 1839: 
1079-1083  
 
33. Kanak, M. Alseiari M,  Balasubramanian P,  Addanki K, Aggarwal M, Noorali S,  Kalsum A, 
Mahalingam K, Pace G,  Panasik N, Bagasra O  (2010) Triplex-forming MicroRNAs Form Stable 
Complexes With HIV-1 Provirus and Inhibit its Replication. Appl. Immunohistochem. Mol. Morphol. 
18:532–545  
 
